Cargando…
The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era
Autores principales: | Quraishi, Mohammed Nabil, Shabir, Sahida, Manzoor, Susan E, Green, Christopher A, Sharma, Naveen, Beggs, Andrew D, Iqbal, Tariq H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906665/ https://www.ncbi.nlm.nih.gov/pubmed/33655227 http://dx.doi.org/10.1016/S2666-5247(21)00036-7 |
Ejemplares similares
-
Multi-modality detection of SARS-CoV-2 in faecal donor samples for transplantation and in asymptomatic emergency surgical admissions
por: Manzoor, Susan E., et al.
Publicado: (2021) -
Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward
por: Green, Christopher A, et al.
Publicado: (2020) -
Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis
por: Rees, Nia Paddison, et al.
Publicado: (2022) -
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel
por: Ianiro, Gianluca, et al.
Publicado: (2022) -
Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease
por: Yalchin, Mehmet, et al.
Publicado: (2019)